StockLens

Max Healthcare Institute Limited (MAXHEALTH) share price and analysis

MAXHEALTH last traded at ₹1,030.90 (+2.08%) on the NSE. Market cap ₹1,00,340 Cr (Large cap), Pharma & Healthcare sector.

Overall rating: 4.6/10 (Average)

Long-term view: Neutral (watchlist). A mixed picture. Wait for better value or a clearer trend. Trade bias (next few weeks): No clear edge. Signals conflict. Sit it out or keep positions small.

Strengths of MAXHEALTH

Weaknesses of MAXHEALTH

Key numbers

NumberValueAssessmentNormal range
P/E (TTM)73.0Expensive vs peers37.0–49.3 (sector median 41.1)
Forward P/E45.0Profits expected to growbelow today's P/E (73.0) and near 41
Price / book8.86High2–6
EPS (TTM)₹14.13Profitableabove ₹0
Return on equity12.8%Average15%+ (below 10% is weak)
Debt / equity0.33Low debtbelow 1.0 (under 0.5 is great)
Net margin15.1%Healthy10%+ (below 5% is thin)
Operating margin21.4%Strong20%+ strong, below 10% thin
Revenue growth+20.3%Growing well10%+ a year (below 3% is weak)
Profit growth-15.5%Falling10%+ a year (falling is weak)
Dividend yield0.20%Small payout1.5%+ (none is fine for growth firms)
Current ratio0.84Tight1.5+ (below 1 is tight)
52W high₹1,185.4013% below · near the highprice in the top 40% of its 52-week range
52W low₹797.00Price is 29% above it
50-DMA₹939.19Price 9.8% aboveprice above it = short-term uptrend
200-DMA₹1,009.80Price 2.1% aboveprice above it = long-term uptrend
1Y return-6.1%Lagged the Nifty 50Nifty 50 did −0.4%
Beta0.18Steadier than the market0.8–1.3 (1 = moves with market)
Promoter / insider28.1%Moderate stake50%+ shows owner commitment
Institutions58.0%Strong big-investor interest30%+ is strong
Analyst target₹1,104.897.2% upside · 27 analysts8%+ upside

Questions about MAXHEALTH

What is the share price of Max Healthcare Institute Limited (MAXHEALTH) today?

MAXHEALTH last traded at ₹1,030.90 (+2.08% on the day) on the NSE. Its 52-week range is ₹797.00 to ₹1,185.40. Prices are delayed and come from Yahoo Finance.

Is MAXHEALTH a good stock for the long term?

StockLens rates MAXHEALTH 4.6 out of 10 (Average) overall. Its long-term verdict is "Neutral (watchlist)": A mixed picture. Wait for better value or a clearer trend. Strengths: revenue growth, low debt, uptrend. Concerns: expensive vs peers, falling profits, bearish moving averages.

Is MAXHEALTH share overvalued?

MAXHEALTH trades at a P/E of 73.0 against a Pharma & Healthcare median of 41.1, which StockLens rates as "Expensive vs peers". Its price-to-book ratio is 8.86.

Is MAXHEALTH good for short-term trading?

The trade bias for the next few weeks is "No clear edge": Signals conflict. Sit it out or keep positions small. The price is 2.1% above its 200-day average and 14-day RSI is 76.

Which stocks are similar to MAXHEALTH?

Similar Pharma & Healthcare stocks of comparable size include Aurobindo Pharma, Cipla, Lupin, Dr. Reddy's Laboratories, Zydus Lifesciences. You can compare up to 4 of them side by side on StockLens.

About Max Healthcare Institute Limited

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and Max Lab, which provides diagnostic testing services to patients. In addition, it offers organ and tissue donation, preventive health checks, ambulance and immigration, air ambulance, and insurance and TPA services. The company provides healthcare services through a network of primary care clinics, multi-specialty hospitals/medical centres, and super-specialty hospital facilities. Max Healthcare Institute Limited was incorporated in 2001 and is based in Gurugram, India.

Stocks similar to MAXHEALTH

Compare MAXHEALTH with AUROPHARMA, CIPLA, LUPIN

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.